Involvement of CD4⁺ cells in the protection of C58 mouse against polioencephalomyelitis induced by lactate dehydrogenase-elevating virus

References

• Anderson G W, Even C, Rowland R R R, Palmer G A, Harty J T, Plagemann P G W. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase‐elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age. J Neurovirol 1995a; 1: 244–252
   PubMed Web of Science ®Google Scholar
• Anderson G W, Palmer G A, Rowland R R R, Even C, Plagemann P G W. Infection of central nervous system cells by ecotropic murine leukemia virus in C58 and AKR mice and in inutero‐infected CE/J mice predisposes mice to paralytic infection by lactate dehydrogenase‐elevating virus. J Virol 1995b; 69: 308–319
   Google Scholar
• Bentley D M, Morris R E. T cell subsets required for protection against age‐dependent polioence‐phalomyelitis. J Immunol 1982; 128: 530–534
   Google Scholar
• Bentley D M, Watson S R, Morris R E. Age‐related loss of Lyt‐1,2 cells in C58 mice results in susceptibility to lactic dehydrogenase virus‐induced polioencephalomyelitis. Inf Immun 1983; 41: 1389–1390
   Google Scholar
• Cafruny W A, Strancke C R, Kowalchyk K, Plagemann P G W. Replication of lactate dehydrogenase‐elevating virus in C58 mice and quantification of antiviral antibodies and of tissue virus levels as a function of development of paralytic disease. J Gen Virol 1986; 67: 27–37
   Google Scholar
• Contag C H, Plagemann P G W. Susceptibility of C58 mice to paralytic disease induced by lactate dehydrogenase‐elevating virus correlates with increased expression of endogenous retrovirus in motor neurons. Microb Pathog 1988; 5: 287–296
   Google Scholar
• Contag C H, Plagemann P G W. Age‐dependent poliomyelitis of mice: expression of endogenous retrovirus correlates with cytocidal replication of lactate dehydrogenase‐elevating virus in motor neurons. J Virol 1989; 63: 4362–4369
   PubMed Web of Science ®Google Scholar
• Coulie P G, Coutelier J P, Uyttenhove C, Lambotte P, Van Snick J. In vivo supp ression of T‐dependent antibody responses by treatment with a monoclonal anti‐L3T4 antibody. Eur J Immunol 1985; 15: 638–640
   Google Scholar
• Coutelier J P, Coulie P G, Wauters P, Heremans H, van der Logt J T M. In vivo polyclonal B‐lymphocyte activation elicited by murine viruses. J Virol 1990; 64: 5383–5388
   PubMed Web of Science ®Google Scholar
• Coutelier J P, Johnston S J, El Azami El Idrissi M, Pfau C J. Involvement of CD4+ cells in lymphocytic choriomeningitis virus‐induced autoimmune anaemia and hypergammaglobulinaemia. J Autoimmunity 1994; 7: 589–599
   PubMed Web of Science ®Google Scholar
• Coutelier J P, Van Broeck J, Wolf S F. Interleukin‐12 gene expression after viral infection in the mouse. J Virol 1995; 69: 1955–1958
   PubMed Web of Science ®Google Scholar
• Coutelier J P, Van Roost E, Lambotte P, Van Snick J. The murine antibody response to lactate dehydrogenase‐elevating virus. J Gen Virol 1986; 67: 1099–1108
   PubMed Web of Science ®Google Scholar
• Coutelier J P, Van Snick J. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur J Immunol 1985; 15: 250–255
   Google Scholar
• Dialynas D P, Wilde D B, Marrack P, Pierres A, Wall K A, Havran W, Otten G, Loken M R, Pierres M, Kapp ler J, Fitch F W. Characterization of the murine antigenic determinant, designated L3T4a, recognized by monoclonal antibody GK1.5: expression of L3T4a by functional T cell clones app ears to correlate primarily with class II antigen‐reactivity. Immunological Rev 1983; 74: 29–56
   PubMed Web of Science ®Google Scholar
• Duffey P S, Martinez D, Abrams G D, Murphy W H. Pathogenic mechanisms in immune polioence phalomyelitis: induction of disease in immunosupp ressed mice. J Immunol 1976; 116: 475–481
   Google Scholar
• Faaberg K S, Palmer G A, Even C, Anderson G W, Plagemann P G W. Differential glycosylation of the ectodomain of the primary envelope glycoprotein of two strains of lactate dehydrogenase‐elevating virus that differ in neuropathogenicity. Virus Res 1995; 39: 331–340
   Google Scholar
• Godeny E K, Chen L, Kumar S N, Methven S L, Koonin E V, Brinton M A. Complete genomic sequence and phylogenetic analysis of the lactate dehydrogenase‐elevating virus (LDV). Virology 1993; 194: 585–596
   Google Scholar
• Harty J T, Chan S P K, Contag C H, Plagemann P G W. Protection of C58 mice from lactate dehydrogenase‐elevating virus‐induced motor neuron disease by non‐neutralizing antiviral antibodies without interference with virus replication. J Neuroimmunol 1987; 15: 195–206
   Google Scholar
• Harty J T, Plagemann P G W. Monoclonal antibody protection from age‐dependent poliomyelitis: implications regarding the pathogenesis of lactate dehydrogenase‐elevating virus. J Virol 1990; 64: 6257–6262
   Google Scholar
• Heemskerk M H M, Schoemaker H M, Spaan W J M, Boog C J P. Predominance of MHC class II‐restricted CD4+ cytotoxic T cells against mouse hepatitis virus A59. Immunology 1995; 84: 521–527
   Google Scholar
• Inada T, Kikuchi H, Yamazaki S. Comparison of the ability of lactate dehydrogenase‐elevating virus and its virion RNA to infect murine leukemia virus‐infected or ‐uninfected cell lines. J Virol 1993; 67: 5698–5703
   Google Scholar
• Ledbetter J A, Herzenberg L A. Xeno‐geneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 1979; 47: 63–90
   PubMed Web of Science ®Google Scholar
• Li X, Hu B, Harty J, Even C, Plagemann P G W. Polyclonal B cell activation of IgG2a and IgG2b production by infection of mice with lactate dehydrogenase‐elevating virus is partly dependent on CD4+ lymphocytes. Viral Immunology 1990; 3: 273–288
   Google Scholar
• Martinez D, Brinton M A, Tachovsky T G, Phelps A H. Identification of lactate dehydrogenase‐elevating virus as the etiological agent of genetically restricted, age‐dependent polioencephalomyelitis of mice. Infect Immun 1980; 27: 979–987
   Google Scholar
• Monteyne P, Van Broeck J, Van Snick J, Coutelier J P. Inhibition by lactate dehydrogenase‐elevating virus of in vivo interleukin 4 production during immunization with keyhole limpet haemocyanin. Cytokine 1993; 5: 394–397
   Google Scholar
• Murphy W H, Nawrocki J F, Pease L R. Age‐dependent paralytic viral infection in C58 mice: possible implications in human neurologic disease. Prog Brain Res 1983; 59: 291–303
   Google Scholar
• Nawrocki J F, Pease L R, Murphy W H. Etiologic role of lactic dehydrogenase virus infection in an age‐dependent neuroparalytic disease in C58 mice. Virology 1980; 103: 259–264
   Google Scholar
• Onyekaba C O, Harty J T, Even C, Hu Bg, Plagemann P G W. Persistent infection of mice by lactate dehydrogenase‐elevating virus: effects of immunosupp ression on virus replication and antiviral immune responses. Virus Research 1989; 14: 297–316
   Google Scholar
• Palmer G A, Kuo L, Chen Z, Faaberg K S, Plagemann P G. Sequence of the genome of lactate dehydrogenase‐elevating virus: heterogenicity between strains P and C. Virology 1995; 209: 637–642
   Google Scholar
• Pease L R, Abrams G D, Murphy W H. FV‐1 restriction of age‐dependent paralytic lactic dehydrogenase virus infection. Virology 1982; 117: 29–37
   Google Scholar
• Pease L R, Murphy W H. Co‐infection by lactic dehydrogenase virus and C‐type retrovirus elicits neurological disease. Nature (London) 1980; 286: 398–400
   Google Scholar
• Stroop W G, Brinton M A. Mouse strain‐specific central nervous system lesions associated with lactate dehydrogenase‐elevating virus infection. Lab Invest 1983; 49: 334–345
   Google Scholar
• Williamson J S P, Stohlman S A. Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol 1990; 64: 4589–4592
   PubMed Web of Science ®Google Scholar